MPM Oncology Impact Management GP LLC's Net Worth
$468 Million
Who is MPM Oncology Impact Management GP LLC?
MPM Oncology Impact Management GP LLC has an estimated net worth of $468 Million. This is based on reported shares across multiple companies, which include Werewolf Therapeutics, Inc., iTeos Therapeutics, Inc., Spring Bank Pharmaceuticals, Inc., Harpoon Therapeutics, Inc., TCR2 THERAPEUTICS INC., SUNESIS PHARMACEUTICALS INC, Oncorus, Inc., and Cullinan Oncology, Inc..
SEC CIK
MPM Oncology Impact Management GP LLC's CIK is 0001721035
Past Insider Trading and Trends
2020 was MPM Oncology Impact Management GP LLC's most active year for acquiring shares with 24 total transactions. MPM Oncology Impact Management GP LLC's most active month to acquire stocks was the month of June. 2021 was MPM Oncology Impact Management GP LLC's most active year for disposing of shares, totalling 67 transactions. MPM Oncology Impact Management GP LLC's most active month to dispose stocks was the month of March. 2019 saw MPM Oncology Impact Management GP LLC paying a total of $13,506,258.12 for 7,269,851 shares, this is the most they've acquired in one year. In 2021 MPM Oncology Impact Management GP LLC cashed out on 60,306,699 shares for a total of $21,911,769.21, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
iTeos Therapeutics, Inc. (ITOS) Snapshot price: $10.52
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.00% | -200.00 |
$29.99 | -$5,998.00 | 6M |
Scheduled
|
Apr 9
| ||
Form 4
| -0.95% | -57.65K |
$30.99 | -$1,300,850.41 | 6M |
Scheduled
|
Apr 7 - Apr 8
| ||
Form 4
| +64.51% | 6.06M |
$19.00 | $6,080,000.00 | 15.46M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Werewolf Therapeutics, Inc. (HOWL) Snapshot price: $6.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,346.05% | 6.21M |
$16.00 |
—
| 6.67M |
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Harpoon Therapeutics, Inc. (HARP) Snapshot price: $22.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.90% | -57.49K |
$20.63 | -$1,186,189.84 | 6.33M |
Scheduled
|
May 28 - Jun 2
| ||
Form 4
| -0.27% | -17.16K |
$20.22 | -$346,937.78 | 6.39M |
Scheduled
|
May 26 - May 27
| ||
Form 4
| -0.25% | -15.91K |
$20.18 | -$321,030.47 | 6.4M |
Scheduled
|
May 21 - May 24
| ||
Form 4
| -0.74% | -47.95K |
$20.49 | -$982,226.63 | 6.42M |
Scheduled
|
May 18 - May 20
| ||
Form 4
| -0.25% | -16.42K |
$20.05 | -$329,313.92 | 6.47M |
Scheduled
|
May 13 - May 17
| ||
Form 4
| -1.04% | -68.26K |
$21.04 | -$1,436,555.54 | 6.48M |
Scheduled
|
May 10 - May 12
| ||
Form 4
| -0.16% | -10.17K |
$22.52 | -$229,107.07 | 6.55M |
Scheduled
|
May 5
| ||
Form 4
| -4.77% | -328.52K |
$22.48 | -$7,386,435.35 | 6.56M |
Scheduled
|
Apr 30 - May 4
| ||
Form 4
| -1.85% | -130.14K |
$21.99 | -$2,861,368.42 | 6.89M |
Scheduled
|
Apr 27 - Apr 29
| ||
Form 4
| -0.13% | -8.97K |
$18.97 | -$170,229.38 | 7.02M |
Scheduled
|
Apr 21
| ||
Form 4
| -0.54% | -38.15K |
$19.04 | -$726,550.34 | 7.03M |
Scheduled
|
Apr 16 - Apr 20
| ||
Form 4
| -0.54% | -38.56K |
$20.16 | -$777,359.18 | 7.07M |
Scheduled
|
Apr 13 - Apr 15
| ||
Form 4
| -0.43% | -30.93K |
$21.90 | -$677,357.16 | 7.11M |
Scheduled
|
Apr 9 - Apr 12
| ||
Form 4
|
∞
| 3.9M |
$11.65 | -$6,258.00 | 3.9M |
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spring Bank Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TCR2 THERAPEUTICS INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.37M |
$15.00 |
—
| 3.37M |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||